Emma Andersson

3.5k total citations
25 papers, 1.3k citations indexed

About

Emma Andersson is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Emma Andersson has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Emma Andersson's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and Antimicrobial Peptides and Activities (5 papers). Emma Andersson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and Antimicrobial Peptides and Activities (5 papers). Emma Andersson collaborates with scholars based in Finland, Sweden and United States. Emma Andersson's co-authors include Lars Björck, Artur Schmidtchen, Hans Tapper, Inga‐Maria Frick, Satu Mustjoki, Victoria Rydengård, Matthias Mörgelin, Andreas Sonesson, Kimmo Porkka and Pekka Ellonen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Emma Andersson

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Andersson Finland 15 537 491 480 269 267 25 1.3k
Brigitte Lemercier France 16 481 0.9× 116 0.2× 276 0.6× 68 0.3× 91 0.3× 21 952
Fazel Shokri Iran 21 611 1.1× 83 0.2× 406 0.8× 142 0.5× 71 0.3× 74 1.2k
Juan R. de los Toyos Spain 19 410 0.8× 93 0.2× 676 1.4× 50 0.2× 67 0.3× 48 1.7k
Ryan W. Feathers United States 12 340 0.6× 278 0.6× 638 1.3× 79 0.3× 35 0.1× 20 1.3k
С. Н. Быковская Russia 11 1.3k 2.4× 981 2.0× 626 1.3× 39 0.1× 82 0.3× 15 2.1k
Takashi Oono Japan 20 169 0.3× 139 0.3× 332 0.7× 41 0.2× 208 0.8× 60 1.2k
Monique Barel France 24 621 1.2× 49 0.1× 725 1.5× 117 0.4× 117 0.4× 70 1.6k
Andrew W. Heath United Kingdom 24 2.0k 3.7× 104 0.2× 502 1.0× 76 0.3× 56 0.2× 70 2.7k
Tamara Lushnikova United States 24 204 0.4× 793 1.6× 1.2k 2.5× 38 0.1× 94 0.4× 34 1.8k
Marije B. Overdijk Netherlands 19 386 0.7× 104 0.2× 597 1.2× 223 0.8× 69 0.3× 32 1.5k

Countries citing papers authored by Emma Andersson

Since Specialization
Citations

This map shows the geographic impact of Emma Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Andersson more than expected).

Fields of papers citing papers by Emma Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Andersson. The network helps show where Emma Andersson may publish in the future.

Co-authorship network of co-authors of Emma Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Andersson. A scholar is included among the top collaborators of Emma Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Andersson. Emma Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattila, Kalle, Siru Mäkelä, Soili Kytölä, et al.. (2022). Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta Oncologica. 61(10). 1263–1267. 4 indexed citations
2.
Holm, Matilda, Emma Andersson, Emerik Österlund, et al.. (2020). Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PLoS ONE. 15(11). e0239819–e0239819. 62 indexed citations
3.
He, Liye, Jing Tang, Emma Andersson, et al.. (2018). Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients. Cancer Research. 78(9). 2407–2418. 55 indexed citations
4.
Lissina, Anna, James E. McLaren, Mette Ilander, et al.. (2018). Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions. Scientific Reports. 8(1). 2534–2534. 2 indexed citations
5.
Majumder, Muntasir Mamun, Monica Hellesøy, Paul Dowling, et al.. (2018). Multi-Parametric Single Cell Profiling Defines Distinct Drug Responses in Healthy Hematological Cell Lineages That Are Retained in Corresponding Malignant Cell Types. Blood. 132(Supplement 1). 264–264. 1 indexed citations
6.
Savola, Paula, Tiina Kelkka, Hanna Rajala, et al.. (2017). Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis. Nature Communications. 8(1). 15869–15869. 78 indexed citations
7.
Coppe, Alessandro, Emma Andersson, Vanessa Rebecca Gasparini, et al.. (2017). Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach. Leukemia. 31(5). 1243–1246. 26 indexed citations
8.
Eide, Christopher A., Swapnil Potdar, Heikki Kuusanmäki, et al.. (2017). Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors. Oncotarget. 8(14). 22606–22615. 15 indexed citations
9.
Pemovska, Tea, Mika Kontro, Bhagwan Yadav, et al.. (2015). Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing. Blood Cancer Journal. 5(5). e309–e309. 18 indexed citations
10.
Rajala, Hanna, Thomas L. Olson, Michael J. Clemente, et al.. (2014). The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica. 100(1). 91–99. 68 indexed citations
11.
Andersson, Emma, Leopold Sellner, Małgorzata Oleś, et al.. (2014). Discovery of Novel Drug Sensitivities in T-Prolymphocytic Leukemia (T-PLL) By High-Throughput Ex Vivo Drug Testing and Genetic Profiling. Blood. 124(21). 917–917. 1 indexed citations
12.
Andersson, Emma, Tea Pemovska, Anneli Lauhio, et al.. (2014). 826: Primary T-prolymphocytic leukemia (T-PLL) cells are sensitive to BCL-2 and HDAC inhibitors: Results from high-throughput ex vivo drug testing. European Journal of Cancer. 50. S200–S200. 1 indexed citations
13.
Andersson, Emma, Hanna Rajala, Samuli Eldfors, et al.. (2013). Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation. Blood Cancer Journal. 3(12). e168–e168. 44 indexed citations
14.
Rajala, Hanna, Samuli Eldfors, Heikki Kuusanmäki, et al.. (2013). Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 121(22). 4541–4550. 195 indexed citations
15.
Andersson, Emma, et al.. (2007). Determination of reducing ends with flow injection analysis with amperometric detection: application to enzyme-hydrolysed methyl cellulose. Analytical and Bioanalytical Chemistry. 387(7). 2585–2593. 3 indexed citations
16.
Andersson, Emma, Victoria Rydengård, Andreas Sonesson, et al.. (2004). Antimicrobial activities of heparin‐binding peptides. European Journal of Biochemistry. 271(6). 1219–1226. 155 indexed citations
17.
Sørensen, Ole E., Lone Gram, Anders H. Johnsen, et al.. (2003). Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin. Journal of Biological Chemistry. 278(31). 28540–28546. 131 indexed citations
18.
Sørensen, Ole E., Lone Gram, Anders H. Johnsen, et al.. (2003). A NOVEL MECHANISM OF GENERATING ANTIMICROBIAL PEPTIDES IN VAGINA. 3 indexed citations
19.
Schmidtchen, Artur, Inga‐Maria Frick, Emma Andersson, Hans Tapper, & Lars Björck. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37. Molecular Microbiology. 46(1). 157–168. 338 indexed citations
20.
Andersson, Emma. (2002). Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Human Reproduction. 17(10). 2529–2534. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Lemercier Breakdown of academic impact, for papers by Fazel Shokri Breakdown of academic impact, for papers by Juan R. de los Toyos Breakdown of academic impact, for papers by Ryan W. Feathers Breakdown of academic impact, for papers by С. Н. Быковская Breakdown of academic impact, for papers by Takashi Oono Breakdown of academic impact, for papers by Monique Barel Breakdown of academic impact, for papers by Andrew W. Heath Breakdown of academic impact, for papers by Tamara Lushnikova Breakdown of academic impact, for papers by Marije B. Overdijk
Rankless by CCL
2026